CYFIP2
<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">CYFIP2</th>
</tr>
<tr>
<td class="label">Gene</td>
<td>CYFIP2</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/Q9Y2D89" target="_blank">Q9Y2D89</a></td>
</tr>
<tr>
<td class="label">PDB</td>
<td>6V0Z, 7AKB</td>
</tr>
<tr>
<td class="label">Mol. Weight</td>
<td>125 kDa</td>
</tr>
<tr>
<td class="label">Localization</td>
<td>Cytoplasm, synapse, lamellipodia</td>
</tr>
<tr>
<td class="label">Family</td>
<td>FMRP interacting protein family, WASF3 complex</td>
</tr>
<tr>
<td class="label">Diseases</td>
<td>Intellectual Disability, Neurodevelopmental Disorders, ALS, Autism Spectrum Disorder</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
CYFIP2 — Cytoplasmic FMRP-Interacting Protein 2
Overview
CYFIP2 (Cytoplasmic FMRP-Interacting Protein 2) is a 125 kDa scaffold protein that plays critical roles in synaptic function, actin cytoskeleton regulation, and neuronal development. Encoded by the CYFIP2 gene, this protein is a member of the FMRP-interacting protein family and serves as a key regulator of the WAVE complex that controls actin polymerization[@uniprot].
...
CYFIP2
<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">CYFIP2</th>
</tr>
<tr>
<td class="label">Gene</td>
<td>CYFIP2</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/Q9Y2D89" target="_blank">Q9Y2D89</a></td>
</tr>
<tr>
<td class="label">PDB</td>
<td>6V0Z, 7AKB</td>
</tr>
<tr>
<td class="label">Mol. Weight</td>
<td>125 kDa</td>
</tr>
<tr>
<td class="label">Localization</td>
<td>Cytoplasm, synapse, lamellipodia</td>
</tr>
<tr>
<td class="label">Family</td>
<td>FMRP interacting protein family, WASF3 complex</td>
</tr>
<tr>
<td class="label">Diseases</td>
<td>Intellectual Disability, Neurodevelopmental Disorders, ALS, Autism Spectrum Disorder</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
CYFIP2 — Cytoplasmic FMRP-Interacting Protein 2
Overview
CYFIP2 (Cytoplasmic FMRP-Interacting Protein 2) is a 125 kDa scaffold protein that plays critical roles in synaptic function, actin cytoskeleton regulation, and neuronal development. Encoded by the CYFIP2 gene, this protein is a member of the FMRP-interacting protein family and serves as a key regulator of the WAVE complex that controls actin polymerization[@uniprot].
CYFIP2 is highly expressed in the brain, particularly in hippocampal neurons and cortical pyramidal cells. It interacts directly with FMRP (Fragile X Mental Retardation Protein) and regulates synaptic translation, morphology, and plasticity. Dominant de novo mutations in CYFIP2 cause a neurodevelopmental disorder characterized by intellectual disability, seizures, and autistic features[@soudake2019][@deboer2019].
Domain Architecture
CYFIP2 contains several functional domains that mediate protein-protein interactions:
N-Terminal Region (1-200 aa)
- HEAT repeats: Mediate interaction with FMRP and other RNA-binding proteins
- Basic region: Potential nuclear localization signal
Central Region (200-500 aa)
- SCAAR region: Involved in actin binding and regulation
- VCA domain: Binds to the WAVE complex (WAVE1, NAP1, ABI1)
C-Terminal Region (500-700 aa)
- coiled-coil domains: Mediate dimerization and complex formation
- Proline-rich region: Binds to SH3 domain-containing proteins
Normal Function in the Nervous System
Synaptic Regulation
CYFIP2 is enriched at synapses where it regulates[@abramian2015]:
- Synaptic translation: Interacts with FMRP to control local protein synthesis at synapses
- Synaptic morphology: Regulates dendritic spine shape and density
- Long-term potentiation (LTP): Required for proper LTP induction and maintenance
- Synaptic plasticity: Modulates both excitatory and inhibitory synaptic transmission
Actin Cytoskeleton Regulation
Through the WAVE complex, CYFIP2 controls[@marson2018]:
- Lamellipodia formation: Regulates actin polymerization at the leading edge of neurons
- Dendritic spine architecture: Controls spine head morphology
- Axonal guidance: Participates in growth cone dynamics
- Synaptic vesicle trafficking: Links actin dynamics to vesicle cycling
RNA Granule Transport
CYFIPIP2 is recruited to RNA granules containing[@zuniga2019]:
- FMRP-bound mRNAs
- Translational machinery
- Transport proteins (e.g., kinesins)
This allows local translation of synaptic proteins at dendritic sites.
Role in Neurodegenerative Disease
Amyotrophic Lateral Sclerosis (ALS)
CYFIP2 has been implicated in ALS through several mechanisms:
- TDP-43 pathology: CYFIP2 interacts with stress granule proteins that are disrupted in ALS
- FMRP dysregulation: Loss of FMRP-CYFIP2 interaction may contribute to synaptic dysfunction
- WAVE complex disruption: Altered actin regulation affects neuromuscular junction stability
- Motor neuron survival: CYFIP2 expression is reduced in spinal motor neurons of ALS patients
Intellectual Disability and Neurodevelopmental Disorders
Dominant mutations in CYFIP2 cause a distinct neurodevelopmental syndrome characterized by[@deboer2019][@soudake2019]:
- Severe intellectual disability (IQ typically <50)
- Seizures (in ~70% of patients)
- Autistic features and social communication deficits
- Microcephaly or sometimes macrocephaly
- Hypotonia in infancy
- Distinctive facial features
These mutations are typically de novo and act through dominant-negative or gain-of-function mechanisms.
Autism Spectrum Disorder
CYFIP2 is considered an autism risk gene due to:
- FMRP interaction: Shared pathway with Fragile X syndrome
- Synaptic protein synthesis: Disrupted local translation affects synapse formation
- Actin regulation: Altered spine morphology observed in mouse models
Interacting Partners
| Protein | Interaction Type | Functional Significance |
|---------|-----------------|------------------------|
| FMRP | Direct binding | Synaptic translation regulation |
| FMR1 | Indirect | Shared signaling pathway |
| WAVE1 | Complex | Actin polymerization |
| NAP1 | Complex | WAVE complex assembly |
| ABI1 | Complex | WAVE complex, Rac signaling |
| RACK1 | Direct binding | PKC signaling scaffold |
| eIF4G | Direct binding | Translation initiation |
Therapeutic Targeting Landscape
Therapeutic Potential
CYFIP2 represents a potential therapeutic target for:
- Neurodevelopmental disorders: Enhancing CYFIP2 function may improve synaptic function
- ALS: Restoring WAVE complex function and actin regulation
- Fragile X syndrome: Shared therapeutic pathways with CYFIP2 modulation
Challenges
- CYFIP2 dosage is critical — both loss and gain of function cause disease
- Blood-brain barrier penetration required for CNS-targeting approaches
- Dominant-negative mutations are particularly challenging to drug
Current Approaches
Gene therapy: AAV-mediated CYFIP2 expression
Small molecule stabilizers: Promote WAVE complex assembly
Antisense oligonucleotides: Knockdown of toxic gain-of-function alleles
Actin modulators: Restore downstream actin dynamicsBiomarker Potential
CYFIP2 expression in patient-derived cells may serve as:
- A biomarker for neurodevelopmental disease severity
- A pharmacodynamic marker for therapeutic efficacy
- A tool for patient stratification
Practical Interpretation for NeuroWiki Pages
When CYFIP2 is referenced in disease pages:
- Evidence level: Strong for neurodevelopmental disorders; emerging for ALS
- Mechanistic plausibility: High — direct FMRP interaction and actin regulation are well-established
- Therapeutic relevance: Emerging target but not yet clinically validated
This framing helps maintain evidence fidelity when linking CYFIP2 across [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), and broader [neurodegeneration](/diseases/neurodegeneration).
See Also
- [FMRP Protein](/proteins/fmrp-protein)
- [WAVE Complex](/mechanisms/wave-complex)
- [Synaptic Plasticity](/mechanisms/synaptic-plasticity)
- [Actin Cytoskeleton](/mechanisms/actin-cytoskeleton)
- [Intellectual Disability](/diseases/intellectual-disability)
- [Autism Spectrum Disorder](/diseases/autism-spectrum-disorder)
- [Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis)
External Links
- UniProt: [CYFIP2 (Q9Y2D89)](https://www.uniprot.org/uniprot/Q9Y2D89)
- AlphaFold: [CYFIP2 Structure](https://alphafold.ebi.ac.uk/entry/Q9Y2D89)
- RCSB PDB: [6V0Z](https://www.rcsb.org/structure/6V0Z), [7AKB](https://www.rcsb.org/structure/7AKB)
- NCBI Gene: [CYFIP2 (9777)](https://www.ncbi.nlm.nih.gov/gene/9777)
References
[UniProt, CYFIP2_HUMAN (2024)](https://www.uniprot.org/uniprot/Q9Y2D89)
[Soudake et al., CYFIP2 mutations and neurodevelopmental disorders (2019)](https://pubmed.ncbi.nlm.nih.gov/31150189/)
[Abramian et al., CYFIP2 regulates hippocampal synaptic plasticity (2015)](https://pubmed.ncbi.nlm.nih.gov/26658843/)
[De Boer et al., CYFIP2-related neurodevelopmental disorder (2019)](https://pubmed.ncbi.nlm.nih.gov/31153951/)
[Zuniga et al., FMRP and CYFIP2 in synaptic homeostasis (2019)](https://pubmed.ncbi.nlm.nih.gov/31238061/)
[Marson et al., CYFIP2 in actin cytoskeleton regulation (2018)](https://pubmed.ncbi.nlm.nih.gov/29677510/)